KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Net Income towards Common Stockholders: 2010-2025

Historic Net Income towards Common Stockholders for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to -$202.4 million.

  • Novavax's Net Income towards Common Stockholders fell 66.84% to -$202.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.7 million, marking a year-over-year increase of 219.97%. This contributed to the annual value of -$187.5 million for FY2024, which is 65.60% up from last year.
  • As of Q3 2025, Novavax's Net Income towards Common Stockholders stood at -$202.4 million, which was down 290.01% from $106.5 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Net Income towards Common Stockholders registered a high of $518.6 million during Q1 2025, and its lowest value of -$846.3 million during Q4 2021.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$121.3 million (2024), whereas its average is -$28.2 million.
  • As far as peak fluctuations go, Novavax's Net Income towards Common Stockholders crashed by 1,910.83% in 2021, and later soared by 451.51% in 2025.
  • Novavax's Net Income towards Common Stockholders (Quarterly) stood at -$846.3 million in 2021, then soared by 78.46% to -$182.2 million in 2022, then increased by 2.12% to -$178.4 million in 2023, then spiked by 54.58% to -$81.0 million in 2024, then tumbled by 66.84% to -$202.4 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$202.4 million for Q3 2025, versus $106.5 million for Q2 2025 and $518.6 million for Q1 2025.